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THIS Supplement contains the papers presented 
at the Satellite Symposium organized by IBSA 
(Switzerland) and Laboratoires Genevrier 
(France): 'Chondroitin Sulfate: Update in Osteoar- 
thritis', held on June 8 1997 in Singapore on the 
occasion of the OARS Congress. Condrosulf ~was 
developed by IBSA and is now available on the 
market in several European countries: Austria, 
Czech Republic, France, Hungary, Italy, Slovak 
Republic and Switzerland. In the course of the 
Symposium, co-chaired by R. D. Altman (Miami, 
Florida), B. A. Michel, (Zurich, Switzerland) and E. 
Vignon (Lyon, France), a group of investigators 
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presented up-to-date pharmacological results, as 
well as those deriving from medium and long-term 
clinical trials, mostly performed in accordance 
with the International Agreements of the Osteoar- 
thritis Research Society. We would like to express 
our grateful thanks to all the authors and the three 
co-chairmen who presided over the Symposium and 
led the discussion for their precious participation. 
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